Saturday, October 3, 2026

USD/EUR Drops By 2% In The Last 21 Sessions

ViaNews Editorial Team

August 22, 2024

USD/EUR Drops By 2% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.45% for the last 21 sessions. At 10:11 EST on Thursday, 22 August, USD/EUR (USDEUR) is $0.90.

USD/EUR's yearly highs and lows, it's 0.424% up from its 52-week low and 5.987% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.29%, a negative 0.13%, and a positive 0.26%, respectively.

USD/EUR's highest amplitude of average volatility was 0.43% (last week), 0.29% (last month), and 0.26% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • Eur/usd weakens below 1.1150 ahead of eurozone/us PMI data. According to FXStreet on Thursday, 22 August, "The EUR/USD pair trades with mild losses near 1.1145, snapping the four-day winning streak during the Asian session on Thursday. "
  • According to FXStreet on Wednesday, 21 August, "Apologies for the obvious comment, but were it not for the mighty dollar, EUR/USD would now be a lot higher.", "And we arereluctant to fight this EUR/USD bull trend ahead of a slowing US economy and the first Fed cut in September."
  • Eur/usd finds fresh 13-month high as greenback pummeling continues. According to FXStreet on Wednesday, 21 August, "The pair has closed in the green for all but one of the last eight straight trading days, with EUR/USD chalking in over 3.5% in gains since the pair's last swing low into the 1.0800 handle before catching a bullish bounce off of the 200-day Exponential Moving Average (EMA), which is now rising into 1.0825."
  • Eur/usd: new range? – rabobank. According to FXStreet on Tuesday, 20 August, "As we argued earlier this month, we see upside risks for EUR/USD as likely to be associated with a softer USD rather than a broadly stronger EUR. ", "On balance, while we can not rule out another dip to the EUR/USD1.08 area in the weeks ahead, we expect EUR/USD to 1.09/1.10 area to become more comfortable for EUR/USD in the coming months."
  • According to FXStreet on Thursday, 22 August, "According to Valeria Bednarik, FXStreet's Chief Analyst, "The EUR/USD pair is technically overbought, yet there are no signs of a change in the dominant trend. ", "In the case of the EUR/USD pair, a corrective decline is now on the table, with supports at 1.1080 and the 1.1000 threshold. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com